Cargando…

Updating Experimental Models of Diabetic Cardiomyopathy

Diabetic cardiomyopathy entails a serious cardiac dysfunction induced by alterations in structure and contractility of the myocardium. This pathology is initiated by changes in energy substrates and occurs in the absence of atherothrombosis, hypertension, or other cardiomyopathies. Inflammation, hyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuentes-Antrás, J., Picatoste, B., Gómez-Hernández, A., Egido, J., Tuñón, J., Lorenzo, Ó.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417999/ https://www.ncbi.nlm.nih.gov/pubmed/25973429 http://dx.doi.org/10.1155/2015/656795

Ejemplares similares

Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation
por: Fuentes-Antrás, J., et al.
Publicado: (2014)

Targeting metabolic disturbance in the diabetic heart
por: Fuentes-Antrás, Jesús, et al.
Publicado: (2015)

Alteration of Energy Substrates and ROS Production in Diabetic Cardiomyopathy
por: Lorenzo, O., et al.
Publicado: (2013)

Potential Role of Nuclear Factor κB in Diabetic Cardiomyopathy
por: Lorenzo, O., et al.
Publicado: (2011)

Diagnostic approaches for diabetic cardiomyopathy
por: Lorenzo-Almorós, A., et al.
Publicado: (2017)

Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
por: Picatoste, Belén, et al.
Publicado: (2013)

Correction: Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
por: Picatoste, Belén, et al.
Publicado: (2013)

Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking
por: Ramírez, E., et al.
Publicado: (2018)

Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases
por: Lorenzo-Almorós, A., et al.
Publicado: (2019)

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes
por: Ramírez, Elisa, et al.
Publicado: (2013)

Role of histone deacetylase inhibitors in diabetic cardiomyopathy in experimental models (Review)
por: Garmpi, Anna, et al.
Publicado: (2022)

Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease
por: Pello Lázaro, Ana María, et al.
Publicado: (2017)

Barth Syndrome Cardiomyopathy: An Update
por: Pang, Jing, et al.
Publicado: (2022)

Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes
por: González, N., et al.
Publicado: (2017)

Update on cardiomyopathies and sudden cardiac death
por: Rizzo, Stefania, et al.
Publicado: (2019)

Experimental Trauma Models: An Update
por: Frink, Michael, et al.
Publicado: (2011)

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy
por: Richter, Claudia, et al.
Publicado: (2021)

Application of Animal Models in Diabetic Cardiomyopathy
por: Lee, Wang-Soo, et al.
Publicado: (2021)

Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
por: Lumpuy-Castillo, Jairo, et al.
Publicado: (2020)

Curcumin Alleviates Diabetic Cardiomyopathy in Experimental Diabetic Rats
por: Yu, Wei, et al.
Publicado: (2012)

Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat
por: Forcheron, Fabien, et al.
Publicado: (2009)

N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients
por: Tuñón, José, et al.
Publicado: (2021)

Diabetic retinopathy: a comprehensive update on in vivo, in vitro and ex vivo experimental models
por: Sadikan, Muhammad Zulfiqah, et al.
Publicado: (2023)

Takotsubo cardiomyopathy following envenomation: An updated review
por: Mishra, Ajay K, et al.
Publicado: (2023)

Diabetic cardiomyopathy
por: Asghar, Omar, et al.
Publicado: (2009)

Of mice and men: models and mechanisms of diabetic cardiomyopathy
por: Riehle, Christian, et al.
Publicado: (2018)

Peripartum Cardiomyopathy: an Update
por: Azibani, Feriel, et al.
Publicado: (2018)

Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors
por: Tuñón, José, et al.
Publicado: (2007)

Update of Takotsubo cardiomyopathy: Present experience and outlook for the future
por: Bairashevskaia, Anastasiia V., et al.
Publicado: (2022)

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023)

Anabolic androgenic steroids and cardiomyopathy: an update
por: Fadah, Kahtan, et al.
Publicado: (2023)

Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy
por: Jiménez-Castilla, Luna, et al.
Publicado: (2021)

The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update
por: Bosman, L. P., et al.
Publicado: (2019)

Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review
por: Fernández-Palanca, Paula, et al.
Publicado: (2021)

Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update
por: te Riele, Anneline SJM, et al.
Publicado: (2014)

Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues
por: Longo, Miriam, et al.
Publicado: (2022)

Peripartum Cardiomyopathy in Intensive Care Unit: An Update
por: Dinic, Vesna, et al.
Publicado: (2015)

Experimental autoimmune uveitis and other animal models of uveitis: An update
por: Bansal, Svati, et al.
Publicado: (2015)

Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update
por: de Oliveira, Diogo Costa Leandro, et al.
Publicado: (2016)

VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy
por: Lavoz, Carolina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4cuqeedidpn3sbmpdu6r6ioaje